Their concerns come in response to the bill unveiled Sunday night by House Republicans that would tighten eligibility rules, ...

In a press conference, President Donald J. Trump announced that he would sign an executive order that ties drug pricing to ...

Homelessness and HIV share common risk factors, according to Julie Dombrowski, M.D., M.P.H., professor of medicine at the ...

Industry leaders and policy experts have said President Trump’s executive order on Most Favored Pricing is flawed and ignores the basic economics of the global drug marketplace.

The House Energy and Commerce Committee has scheduled a public markup hearing for the Republican bill for tomorrow at 2 p.m.

Healthcare providers are exploring ways to reduce patient travel through a growing trend of expanding sites of administration ...

A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

The latest report by Urban Institute warns that proposed Medicaid funding cuts could cost states like California, New York, ...

Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.